Status:
COMPLETED
Effect of Tumor Micronecrosis on Postoperative Transcatheter Arterial Chemoembolization in Patients With Hepatocellular Carcinomas
Lead Sponsor:
Zhejiang University
Conditions:
Carcinoma, Hepatocellular
Eligibility:
All Genders
Brief Summary
Micronecrosis is a novel pathological feature of hepatocellular carcinoma (HCC). This study was aimed at evaluating the effect of tumor micronecrosis on postoperative transcatheter arterial chemoembol...
Eligibility Criteria
Inclusion
- (1) pathologically confirmed HCC (2) achievement of R0 resection.
Exclusion
- (1) simultaneous presence of other tumors ; (2) receipt of preoperative anti-tumoral treatments; (3) concurrent treatment with other antitumoral therapies in combination with TACE; (4) tumor necrosis that could be observed by gross examination; (5) a lack of necessary preoperative laboratory test results.
Key Trial Info
Start Date :
April 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 14 2022
Estimated Enrollment :
900 Patients enrolled
Trial Details
Trial ID
NCT05352204
Start Date
April 30 2020
End Date
April 14 2022
Last Update
February 14 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
the First Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China, 310009
2
the First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China, 310009